Here are five things to know:
1. The total transaction was valued at $15.5 million.
2. Braun Stacey Associates owned about 0.41 percent of AmSurg at the end of the most recent reporting period.
3. AmSurg has a 12-month low of $49.25 and a 12-month high of $87.42.
4. The company has a 50-day moving average of $81.15 and a 200-day moving average of $76.96.
5. The firm has a market cap of $3.91 billion.
More articles on ASC issues:
40 statistics on ASC case mix — Orthopedics, GI, pain & more
Bariatric surgery provides low risk for heart attacks and type 2 diabetes — 5 key findings
26 great books for ASC leaders — 2016 reading list
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
